🔗 Share this article

As the US continues making sweeping changes to its vaccination schedules, an unexpected name appears unexpectedly: Høeg, a US-based sports medicine doctor and epidemiologist who initially gained attention by expressing skepticism about COVID-19 shots in the pandemic and has concentrated on possible fatalities after Covid immunization in her short position at the Food and Drug Administration.

Proposed Shifts to Pediatric Vaccine Schedule

Agency leaders planned to reveal major revisions to the pediatric immunization program in December, synchronizing the US with Denmark’s immunization schedule, according to reports – a significant shift that would place the US out of step with many the global community with no evidence for improved outcomes. The planned update has been delayed until the next year.

In place of the top vaccines chief, Dr. Høeg is set to address the audience at the event. She was newly appointed acting director of the FDA’s CDER, the fifth appointee to run the division this calendar year.

A Shift at the Regulatory Body

Høeg's temporary position may indicate a tighter collaboration between the pharmaceutical and vaccine branches as Dr. Høeg and Dr. Prasad solidify control at the FDA – and it signals a greater focus upon dismantling previously authorized immunizations at the FDA.

Høeg has often pushed for discontinuing specific childhood shot schedules in the US to become more like Denmark, a nation with comprehensive healthcare and a population roughly the size of Wisconsin’s.

So far public appearances, she has continued to focus on vaccination policy – usually the responsibility of Dr. Prasad, chief of the FDA’s Center for Biologics Evaluation and Research (CBER) – rather than drug regulation.

Doubts Over Expertise

Høeg has little discernible track record in pharmaceutical research, approval processes or administrative roles, which has been standard for past leaders of the Center for Biologics Evaluation and Research. She has served at the FDA as a key advisor to the FDA chief and the vaccine center since spring.

“She doesn’t seem to have the necessary background” for running the CDER, stated Jonathan Howard. “She has not conducted a scientific study. She has no expertise in leading a major agency. She is not an expert in industry regulation.”

Previous heads of CBER would “grasp regulatory frameworks and the research of pharmaceutical innovation”, noted Janet Woodcock. “Frankly, she has not acquired the type of experience that prior appointees who led CBER have had.”

This division has an enormous workload at the FDA, she emphasized.

“The public just zeroes in on the new drug program, but the off-patent medication office authorizes numerous off-brand pharmaceuticals. There is also a biosimilars program, over-the-counter program and more, and all of those have to be looked after,” Woodcock noted. “The thing you don’t keep your eye on, that is precisely what that I always told people is going to come back to haunt you.”

There is also, a major management aspect to the role, which manages over 5,000 personnel. “It is a massive leadership role, if you perform it correctly,” Woodcock added.

Official Statement and Controversial Policies

When asked about inquiries about Dr. Høeg's qualifications and whether this assignment represents more teamwork among agency officials on vaccines, a spokesperson stated that the “concerns are based on incorrect presumptions”.

“This background aligns with the functions of her position,” the spokesperson stated, pointing to the period Dr. Høeg spent advising the agency head on “medication safety and approval science, including computational safety modeling and vaccine surveillance”.

As the temporary head, Dr. Høeg assumes responsibility for the agency head's new expedited review system, a disputed one-day therapy clearance system that allegedly worried her former heads. “How are these therapies being picked for this voucher program? Who takes the decisions?” Dr. Howard questioned. “There’s a lot of lack of transparency occurring at the FDA right now.”

In general, he stated, “the agency seems to be moving towards less stringent oversight of most medications, except for shots.”

Documented History on Immunizations

Concerning immunizations, Høeg has a more established, if troubling, history, critics said. She published a study using non-validated crowd-sourced reports to determine the frequency of heart inflammation following COVID-19 immunization. She advised the state of Florida chief medical officer Joseph Ladapo, who reportedly have altered data to imply Covid vaccines are pose a greater threat than they are.

Part of her “desired changes” for the current federal leadership included changing guidelines for new vaccines and halting “optional” vaccines, she stated following the vote on a audio program. At the agency, Dr. Høeg has allegedly suggested excluding teenage boys from receiving Covid vaccinations.

“She’s an thorough true believer who commences with her beliefs and tailors the evidence to retrofit the data in a very deceptive, dishonest fashion,” Howard stated.

Taking Control and a “Push for Payback”

Dr. Høeg became part of fellow skeptics, {like|